Compounds > aminoimidazole carboxamide
Page last updated: 2024-08-21

aminoimidazole carboxamide and Cystic Fibrosis

aminoimidazole carboxamide has been researched along with Cystic Fibrosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Barraja, P; Barreca, M; Cilibrasi, V; Galietta, LJV; Genovese, M; Montalbano, A; Renda, M; Spanò, V1
Baty, CJ; Fitch, AC; Hallows, KR; King, JD; Kolls, JK; Magill, A; Myerburg, MM; Oyster, NM; Pilewski, JM; Watkins, SC1

Other Studies

2 other study(ies) available for aminoimidazole carboxamide and Cystic Fibrosis

ArticleYear
Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein.
    Molecules (Basel, Switzerland), 2021, Feb-26, Volume: 26, Issue:5

    Topics: Aminoimidazole Carboxamide; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Mutant Proteins; Mutation; Protein Folding; Thiazoles

2021
AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells.
    American journal of respiratory cell and molecular biology, 2010, Volume: 42, Issue:6

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Anti-Inflammatory Agents; Cell Polarity; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Cytokines; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Epithelial Cells; Epithelial Sodium Channels; Humans; Inflammation Mediators; Membrane Potentials; Metformin; Microscopy, Confocal; Pneumonia; Respiratory Mucosa; Ribonucleotides; Sodium; Time Factors; Water-Electrolyte Balance

2010